257 related articles for article (PubMed ID: 35545047)
21. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
[TBL] [Abstract][Full Text] [Related]
23. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication.
Fejér G; Medveczky MM; Horvath E; Lane B; Chang Y; Medveczky PG
J Gen Virol; 2003 Jun; 84(Pt 6):1451-1462. PubMed ID: 12771414
[TBL] [Abstract][Full Text] [Related]
24. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.
Zhang F; Liang D; Lin X; Zou Z; Sun R; Wang X; Liang X; Kaye KM; Lan K
PLoS Pathog; 2019 Feb; 15(2):e1007628. PubMed ID: 30811506
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.
Purushothaman P; McDowell ME; McGuinness J; Salas R; Rumjahn SM; Verma SC
J Virol; 2012 Sep; 86(18):9983-94. PubMed ID: 22761383
[TBL] [Abstract][Full Text] [Related]
26. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program.
Li Q; Zhou F; Ye F; Gao SJ
Virology; 2008 Sep; 379(2):234-44. PubMed ID: 18684478
[TBL] [Abstract][Full Text] [Related]
27. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
[TBL] [Abstract][Full Text] [Related]
30. Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation.
Vladimirova O; De Leo A; Deng Z; Wiedmer A; Hayden J; Lieberman PM
PLoS Pathog; 2021 Jan; 17(1):e1009231. PubMed ID: 33471863
[TBL] [Abstract][Full Text] [Related]
31. Regulation of KSHV Latency and Lytic Reactivation.
Broussard G; Damania B
Viruses; 2020 Sep; 12(9):. PubMed ID: 32957532
[TBL] [Abstract][Full Text] [Related]
32.
Pires de Miranda M; Quendera AP; McVey CE; Kaye KM; Simas JP
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111565
[TBL] [Abstract][Full Text] [Related]
33. LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection.
Toth Z; Papp B; Brulois K; Choi YJ; Gao SJ; Jung JU
PLoS Pathog; 2016 Sep; 12(9):e1005878. PubMed ID: 27606464
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome.
Barbera AJ; Chodaparambil JV; Kelley-Clarke B; Luger K; Kaye KM
Cell Cycle; 2006 May; 5(10):1048-52. PubMed ID: 16721045
[TBL] [Abstract][Full Text] [Related]
35. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
Sun Z; Jha HC; Robertson ES
J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
[TBL] [Abstract][Full Text] [Related]
36. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
[TBL] [Abstract][Full Text] [Related]
37. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.
Ballestas ME; Chatis PA; Kaye KM
Science; 1999 Apr; 284(5414):641-4. PubMed ID: 10213686
[TBL] [Abstract][Full Text] [Related]
38. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
Hu J; Garber AC; Renne R
J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.
You J; Srinivasan V; Denis GV; Harrington WJ; Ballestas ME; Kaye KM; Howley PM
J Virol; 2006 Sep; 80(18):8909-19. PubMed ID: 16940503
[TBL] [Abstract][Full Text] [Related]
40. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency.
De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
